LifeNet Health features breakthrough MIS technology at 2022 NASS Annual Meeting
CHICAGO, Oct. 12, 2022 /PRNewswire/ -- LifeNet Health is showcasing the most advanced allograft biologics for fusion during the North American Spine Society (NASS) 2022 Annual Meeting in Chicago Oct. 12-14 (Booth #3216). The global leader in allograft solutions and processing technology will feature the growing body of evidence supporting LifeNet Health's solutions for thoracic, cervical, and lumbar fusions — including ViviGen® Cellular Bone Matrix, PliaFX® Prime moldable demineralized fibers, and VertiGraft® structural allografts.
- The exhibit features ViviGen MIS, the first viable cellular allograft delivery system designed specifically for minimally invasive surgery
CHICAGO, Oct. 12, 2022 /PRNewswire/ -- LifeNet Health is showcasing the most advanced allograft biologics for fusion during the North American Spine Society (NASS) 2022 Annual Meeting in Chicago Oct. 12-14 (Booth #3216). - LifeNet Health has tailored these solutions to overcome clinical challenges ranging from the routine to the most complex fusions, including minimally invasive procedures.
- "Our extensive data, industry-leading technologies, and better biologics are creating better lives," said Rich Rice, LifeNet Health Vice President of Orthopedics & CMF.
- NASS participants can explore peer-reviewed publications with compelling data about the clinical effectiveness of LifeNet Health's solutions.